Cavitation Technologies (CVAT) Stock Price, News & Analysis

Company Overview

Cavitation Technologies, Inc. develops and commercializes industrial fluid‐treatment and cleaning systems that harness the physical process of cavitation. By inducing controlled implosion of microbubbles in liquids—either through hydrodynamic or ultrasonic methods—the company’s equipment can remove scale, oil, biofilm and chemical residues without the need for aggressive solvents or high-pressure blasting. Cavitation’s technology platform is designed to improve efficiency, lower operational costs and reduce environmental impact in a variety of industrial applications.

The company’s product lineup includes bench‐scale and skid‐mounted cavitation reactors, ultrasonic cleaning units and integrated fluid‐handling modules. These solutions are marketed under proprietary brand names and can be configured for tasks such as wastewater treatment, oil‐water separation, surface preparation and chemical reaction acceleration. Cavitation Technologies also offers on‐site technical support, pilot testing services and custom engineering to help clients validate performance and scale up to full production capacity.

Headquartered in the United States, Cavitation Technologies primarily serves customers in the energy, marine, manufacturing and environmental‐services sectors. While the company’s operations are focused on North American markets, it continues to explore strategic partnerships and distribution agreements to broaden its international reach. Cavitation Technologies is led by an experienced management team with backgrounds in fluid dynamics, chemical engineering and industrial equipment commercialization.

Key Stats

• Today's Range: $0.06 to $0.07
• 50-Day Range: $0.03 to $0.07
• 52-Week Range: $0.01 to $0.07
• Volume: 778,421 shs
• Average Volume: 539,133 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Cavitation Technologies Stock Analysis - MarketRank™

Cavitation Technologies scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cavitation Technologies.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cavitation Technologies is -4.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cavitation Technologies is -4.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cavitation Technologies has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cavitation Technologies has recently decreased by 89.23%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cavitation Technologies does not currently pay a dividend.

Dividend Growth

Cavitation Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cavitation Technologies has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cavitation Technologies has recently decreased by 89.23%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Cavitation Technologies this week, compared to 0 articles on an average week.

Search Interest

Only 1 people have searched for CVAT on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cavitation Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

28.11% of the stock of Cavitation Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 8.53% of the stock of Cavitation Technologies is held by institutions.

CVAT Stock Analysis - Frequently Asked Questions

How have CVAT shares performed this year?

Cavitation Technologies' stock was trading at $0.0189 at the beginning of 2025. Since then, CVAT stock has increased by 243.9% and is now trading at $0.0650.

How do I buy shares of Cavitation Technologies?

Shares of CVAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cavitation Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cavitation Technologies investors own include Adamis Pharmaceuticals (ADMP), Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Altimmune (ALT) and Digital Ally Inc./NV (DGLY).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Specialty Industrial Machinery
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:CVAT
• CIK: 1376793
• Web: www.ctinanotech.com
• Phone: (818) 718-0905
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A